S&P 500
(0.11%) 5 254.35 points
Dow J
(0.12%) 39 807 points
Nasdaq
(-0.12%) 16 379 points
Oil
(-0.07%) $83.11
Gas
(-0.62%) $1.752
Gold
(0.73%) $2 254.80
Silver
(0.74%) $25.10
Platinum
(0.21%) $923.00
USD/EUR
(0.00%) $0.927
USD/NOK
(-0.05%) $10.83
USD/GBP
(-0.10%) $0.791
USD/RUB
(-0.21%) $92.38

Realtime updates for IXICO PLC [IXI.L]

Exchange: LSE Industry: Pharmaceuticals, Biotechnology & Life Sciences
Last Updated28 Mar 2024 @ 12:35

-6.36% £ 8.10

Live Chart Being Loaded With Signals

Commentary (28 Mar 2024 @ 12:35):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

IXICO plc provides data analytics services to the biopharmaceutical industry in the United Kingdom, Switzerland, Netherlands, Ireland, rest of Europe, the United States, and internationally...

Stats
Today's Volume 46 877.00
Average Volume 95 774.00
Market Cap 3.92M
EPS £0 ( 2023-12-05 )
Next earnings date ( £0 ) 2024-05-20
Last Dividend £0 ( N/A )
Next Dividend £0 ( N/A )
P/E -4.05
ATR14 £0 (0.00%)

IXICO PLC Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

IXICO PLC Financials

Annual 2023
Revenue: £6.67M
Gross Profit: £2.85M (42.70 %)
EPS: £-0.0244
Q4 2023
Revenue: £3.46M
Gross Profit: £1.57M (45.41 %)
EPS: £-0.00940
Q2 2023
Revenue: £3.20M
Gross Profit: £1.27M (39.78 %)
EPS: £-0.0150
Q4 2022
Revenue: £4.72M
Gross Profit: £2.67M (56.64 %)
EPS: £0.0169

Financial Reports:

No articles found.

IXICO PLC

IXICO plc provides data analytics services to the biopharmaceutical industry in the United Kingdom, Switzerland, Netherlands, Ireland, rest of Europe, the United States, and internationally. Its services include collection, analysis, management, and reporting on data generated in the course of a clinical study. The company's technologies comprise Assessa, a secure online digital platform that provides clinical decision support for patient selection and post-marketing surveillance; and TrialTracker, a platform that delivers imaging services designed to manage the complex imaging workflow from image upload, quality control, and reading/analysis to reporting and data transfer. Its focused therapeutic areas include Alzheimer's, Parkinson's, Huntington's, Multiple Sclerosis and other demyelinating diseases, Progressive Supranuclear Palsy, and other rare neurological diseases. The company also engages in the data collection, optimization, and analytics of rare neurological disorders; offers drug development analytics, imaging operation services, and post marketing surveillance services, as well as consultancy services; and provides end-to-end services, such as trail design and consultation, project management, imaging site set-up and management, data management, reading and analysis, and regulatory pathway. IXICO plc was incorporated in 1995 and is based in London, the United Kingdom.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators